Money Concepts Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.23M Buy
42,448
+463
+1% +$103K 0.51% 42
2025
Q4
$9.59M Buy
41,985
+643
+2% +$146K 0.54% 35
2025
Q3
$9.57M Sell
41,342
-1,146
-3% -$233K 0.59% 31
2025
Q2
$7.89M Buy
42,488
+2,426
+6% +$451K 0.53% 36
2025
Q1
$8.39M Sell
40,062
-2,599
-6% -$505K 0.63% 31
2024
Q4
$7.58M Buy
42,661
+2,021
+5% +$372K 0.56% 36
2024
Q3
$8.03M Sell
40,640
-1,270
-3% -$237K 0.61% 32
2024
Q2
$7.19M Sell
41,910
-531
-1% -$88K 0.6% 34
2024
Q1
$7.73M Sell
42,441
-943
-2% -$163K 0.71% 36
2023
Q4
$6.72M Sell
43,384
-953
-2% -$139K 0.62% 44
2023
Q3
$6.61M Sell
44,337
-1,370
-3% -$201K 0.69% 43
2023
Q2
$6.16M Sell
45,707
-53,256
-54% -$7.81M 0.63% 49
2023
Q1
$15.8M Sell
98,963
-86,370
-47% -$13.2M 0.88% 34
2022
Q4
$30M Buy
185,333
+92,053
+99% +$14.1M 1.34% 18
2022
Q3
$12.5M Buy
93,280
+44,909
+93% +$6.44M 0.74% 40
2022
Q2
$7.44M Sell
48,371
-67,551
-58% -$10.3M 0.66% 31
2022
Q1
$18.8M Buy
115,922
+65,825
+131% +$9.56M 1.06% 13
2021
Q4
$6.78M Buy
+50,097
New +$5.92M 0.57% 38
2021
Q1
$5.18M Buy
47,881
+612
+1% +$65.5K 0.41% 65
2020
Q4
$5.07M Buy
+47,269
New +$4.54M 0.47% 58

Other funds holding ABBV

Money Concepts Capital's ABBV Position: Q1 2026 in Review

Money Concepts Capital increased its AbbVie (ABBV) stake by 1.1% in Q1 2026, buying an estimated $103K and bringing the position to 42,448 shares worth $9.23M. The position accounts for 0.51% of the portfolio, ranked #42.

Money Concepts Capital first reported a position in ABBV in Q4 2020 and has held it in 20 quarters since. The position peaked at $30M in Q4 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Money Concepts Capital held 42,448 shares of AbbVie worth $9.23M as of Q1 2026.
  • Money Concepts Capital bought 463 AbbVie shares in Q1 2026, an estimated $103K.
  • AbbVie made up 0.51% of Money Concepts Capital's portfolio in Q1 2026, its #42 holding.
  • Money Concepts Capital first reported a position in AbbVie in Q4 2020 and has held it in 20 quarters since.
  • Money Concepts Capital's AbbVie position peaked at $30M in Q4 2022.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Money Concepts Capital's 13F filing for Q1 2026, filed 30 Apr 2026.